C-QH3IColossal
gene editing, de-extinction, genetics
research tools
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-QH3I
C-QH3IC-QH3Igene editing, de-extinction, genetics
0-100 chain-logic scale · 15 dimensions · scored on public evidence
In one of the most futuristic and mind-blowing episodes of the Joe Rogan Experience (#2301), tech entrepreneur and Colossal Biosciences founder Ben Lamm joins Joe Rogan to discuss the terrifying and exciting reality of de-extinction. Discover exactly how scientists are using CRISPR gene-editing technology to bring back the extinct Woolly Mammoth, the Tasmanian Tiger, and the Dodo bird. Explore the deep ecological reasons behind these massive projects, how roaming mammoths could literally save the planet from a catastrophic Arctic permafrost carbon explosion, and the serious bioethical boundaries modern science must navigate as we begin to rewrite the genetic history of Earth. #JoeRogan #BenLamm #JRE2301 #ColossalBiosciences #WoollyMammoth #CRISPR #DeExtinction #GeneticEngineering #ClimateSolutions #ScienceMysteries #FutureTech
Avi Loeb's UAP Science Advisory Council added a 13th name. Ben Lamm. He is the co-founder and CEO of Colossal Biosciences, the de-extinction company building woolly mammoths and dire wolves. Loeb seats him for oceanography and biology. Lamm is a biotech entrepreneur, not a working ocean scientist. The roster also keeps moving. Loeb's June 17 follow-up lists 12 names, not 13, and quietly drops a different member who still appears on the main announcement. Full briefing on the council, the board it answers to, and the 3I/ATLAS data it could release: https://thesentinel.network/p/uap-governance-board-loeb-council KEY FACTS - Ben Lamm, co-founder and CEO of Colossal Biosciences - De-extinction company: woolly mammoths, dire wolves - Former founder of the AI firm Hypergiant - Company valuation north of $10 billion - Seated by Loeb for oceanography and biology - 13th name on the UAP Science Advisory Council ABOUT THE SENTINEL NETWORK™ Independent investigative publication. A top 100 Scie
EXCLUSIVE: Ben Lamm from Colossal Biosciences joins Tyrus to reveal a breakthrough that sounds straight out of science fiction — a fully artificial egg system that successfully hatched baby chicks. Ben explains how this technology could one day help bring back extinct animals like the Woolly Mammoth, Dodo, and Dire Wolf, while also helping protect endangered species before they disappear forever. Tyrus and Ben also talk about giant extinct creatures, mysterious ancient discoveries, AI, cloning, conservation, and how science is changing the future faster than most people realize. If you’re fascinated by Jurassic Park-style technology, lost animals, or the future of our planet, this conversation is a must-watch. STAY IN THE ORBIT 🪐 Instagram 👉https://www.instagram.com/planettyruspod/ Facebook 👉https://www.facebook.com/PlanetTyrusPod X 👉https://x.com/PlanetTyrusPod 00:00 - Introduction: The "Einstein" of Biology 03:00 - The South Island Giant Moa: 9-Foot Tall Birds 05:09 - Working
The world’s only de-extinction company, Colossal Biosciences, has today announced the sixth species joining their roster. Adding to the already impressive list of woolly mammoth, dodo, moa, thylacine, and dire wolf is the bluebuck, an antelope species that went extinct around 1800. IFLScience caught up with CEO and Co-Founder Ben Lamm and Chief Animal Officer Matt James to talk all things bluebuck, practical conservation applications, new technology, and if a living, breathing bluebuck is really achievable – and what that might mean for wider antelope conservation. Read more: https://www.iflscience.com/the-plan-is-definitely-to-make-a-living-breathing-bluebuck-colossal-biosciences-announces-the-south-african-bluebuck-as-6th-species-on-its-de-extinction-list-83335
Colossal, the biotech startup working on de-extincting the woolly mammoth and the dodo, thinks it can make trillions of dollars — almost none of it from consumer-facing products. Liz and Rohan dive into it all with CEO Ben Lamm, who has already spun out four businesses as he’s built the bioscience business with a focus on serving governments and nations looking to build drought-resistant plants, plastic-munching microbes, and much more (some of it classified!) Sign up to get Semafor Business in your inbox: https://www.semafor.com/newsletters/business This season of Compound Interest is in partnership with Amazon Business. Amazon Business is a trusted partner that transforms business buying by combining Amazon's vast selection, competitive pricing, and fast delivery with added tools and insights to help businesses simplify purchasing, manage spend, and buy smarter.
This episode was filmed at the 2026 Abundance360 Summit. Learn more at https://www.abundance360.com/ This interview explores the groundbreaking work of Colossal in synthetic biology, de-extinction, and AI integration. Colossal CEO Ben Lamm explains how the company is revolutionizing biodiversity preservation, tackling plastic pollution, and creating living products with immense potential. Get access to metatrends 10+ years before anyone else - https://qr.diamandis.com/metatrends Ben Lamm is Co-founder and CEO of Colossal Biosciences - learn more at https://colossal.com/ Peter H. Diamandis, MD, is the Founder of XPRIZE, Singularity University, ZeroG, and A360 Chapters: 00:00 - Colossal’s Vision on De-Extinction and Rewilding 05:58 - Advancements in Plastic Degradation Technologies 07:10 - Reintroducing Extinct Species and Bio Vaults 12:07 - Artificial Wombs and Species Production 17:00 - Using AI to Engineer Desired Phenotypes 18:00 - Invasive Species Control and Gene Drives 26
Ben Lamm, the CEO and co-founder of @Colossal Biosciences — the world's first de-extinction company — joins Brian Hiatt at The Rolling Stone Studio live at @SXSW, presented by @jbl, to talk about bringing extinct species back to life, the ethics of resurrecting animals, how he could engineer microbes that eat plastic, his plan to build genetic bio vaults around the world, and whether his company could actually make a unicorn. A serial entrepreneur who built and sold five tech companies before turning 40, Lamm partnered with Harvard geneticist George Church in 2021 to launch Colossal, which is now valued at over $10 billion. Last year, the company made headlines with the birth of three dire wolf pups — the first de-extincted mammal — and is on track to produce woolly mammoth embryos by the end of 2026. Colossal also acquired ViaGen, the company that cloned Barbra Streisand's dogs, and spun out Breaking, a startup engineering microbes that eat plastic. Lamm’s newest venture, the Colossa
Ready to learn about the (seemingly) impossible - de-extinction? Hear whether we can bring back the woolly mammoth and all sorts of Ancient DNA fun facts with Ben Lamm of Colossal Biosciences. Ben Lamm, the Founder & CEO of Colossal Biosciences, joins Episode 356 of the Wild Business Growth podcast to share his journey from 5 successful exits to creating the company trying to bring back & de-extinct the woolly mammoth. Hear how to become a serial entrepreneur like Ben Lamm has, the impact of bringing back woolly mammoths through de-extinction & Ancient DNA, whether the world is ready for de-extinction in woolly mammoths & other species, mind-blowing aspects of genetics & Ancient DNA, and the other species Ben wants to bring back through de-extinction & Ancient DNA. Connect with Ben Lamm & Colossal Biosciences: https://colossal.com/ https://x.com/colossal https://www.linkedin.com/in/benlamm/ Chapters: 0:51 Serial Entrepreneurship 4:49 The Colossal Biosciences Story 24:56 Rapid-Fire
Ben Lamm, co-founder and CEO of Colossal Biosciences, joins us at the 2026 Upfront Summit in conversation with Cody Simms (Managing Partner, MCJ) to talk about building the world's first de-extinction company, and what synthetic biology and AI can do for the future of life on Earth. Ben breaks down how Colossal brought back the dire wolf from ancient DNA, what it actually takes to reverse extinction, and why the same technology is already transforming conservation efforts around the world. Topics covered: - How Colossal used ancient DNA to create living dire wolves - The tech stack behind de-extinction: AI, synthetic biology, and artificial wombs - Why de-extinction is also a conservation play - The ethical boundaries Colossal has set for its work - What's coming next: mammoth embryos and endangered species toolkits
Robert walks Langston Kerman through the story of Dr. George Church, a very real scientist who co founded the company making bullshit claims of "de extincting" dire wolves. (2 Part Series) Sources: 1. George Church, Colossal W*nker – For Better Science (https://forbetterscience.com/2023/06/26/george-church-colossal-wnker/) 2. Can Gene Therapy Slow Ageing in Dogs? - Gowing Life (https://www.gowinglife.com/can-gene-therapy-slow-ageing-in-dogs/) 3. Never-ageing Anti-aging to cure COVID-19 – For Better Science (https://forbetterscience.com/2020/05/14/never-ageing-anti-aging-to-cure-covid-19/) 4. The original sins of Leonard Guarente – For Better Science (https://forbetterscience.com/2023/04/17/the-original-sins-of-leonard-guarente/) 5. Jeffrey Epstein Hoped to Seed Human Race With His DNA - The New York Times (https://www.nytimes.com/2019/07/31/business/jeffrey-epstein-eugenics.html) 6.
Is the woolly mammoth really coming back? And why is Dubai building a $60M "BioVault" at the Museum of the Future? Ben Lamm, CEO and co-founder of Colossal Biosciences—the $10.32 billion de-extinction company backed by Paris Hilton, Tom Brady, and the producer of Lord of the Rings—reveals everything in this exclusive interview from Dubai. In this video, Ben Lamm reveals: 🦣 The truth about bringing back the woolly mammoth (and why it's NOT Jurassic Park) 🧬 Why Dubai was chosen for the world's FIRST Colossal BioVault 🌍 The shocking statistic: 50% of all biodiversity could be gone by 2050 💰 How a "de-extinction" company spun out $100M+ companies in healthcare and plastic degradation 🔮 What's coming in 2026 that will blow 2025 away TIMESTAMPS: 0:00 - Intro at World Government Summit, Dubai 0:45 - "We're NOT making dinosaurs" - Ben Lamm's viral myth-buster 2:10 - The 50% biodiversity loss crisis no one is talking about 3:30 - Why Dubai? "The intentionality is unmatched" 5:15 - What
In this conversation titled A Colossal Change in Extinction, Ben Lamm, Co-Founder and CEO of Colossal — the pioneering biotechnology company working to bring back extinct species — joins Anastasios Economou, Founder of iGrow, to explore one of the most ambitious intersections of science, technology, and the future of life on Earth. They discuss: • The science and technology behind de-extinction • Why Colossal is working to revive species such as the woolly mammoth • The broader implications for biodiversity, conservation, and climate restoration • How breakthroughs in genetic engineering are reshaping what is scientifically possible • The ethical, environmental, and commercial implications of synthetic biology This is the full, unedited exchange from Davos — offering insight into how frontier technologies are redefining conservation, reshaping ecosystems, and expanding the boundaries of human innovation. To stay informed on future conversations with global leaders across science, te
"We need to start backing up all life on Earth because while conservation works, it's not working at the speed at which we're eradicating species." Colossal Biosciences CEO Ben Lamm explains de-extinction.
On this episode of Planet Tyrus, Tyrus sits down with Ben Lamm, co-founder and CEO of Colossal Biosciences, the company making de-extinction real. Ben Lamm explains how his team brought the dire wolf back from extinction, using ancient DNA, genetic engineering, and cutting-edge biotechnology. They explore how de-extinction works, why dire wolves were chosen, and how the same science could help save endangered species today. STAY IN THE ORBIT 🪐 Instagram 👉https://www.instagram.com/planettyruspod/ Facebook 👉https://www.facebook.com/PlanetTyrusPod X 👉https://x.com/PlanetTyrusPod 00:00 Dire Wolves Are Back 01:10 Meet Ben Lamm (Colossal Biosciences) 03:20 Dire Wolves vs Game of Thrones 06:20 Why De-Extinction Matters 09:30 Saving Species With DNA 13:40 Artificial Wombs Explained 18:10 Mammoths, Dodos & Giant Sloths 22:30 Dinosaurs, Birds & Evolution 28:40 How Dire Wolves Were Created 34:20 Can Dire Wolves Breed? 39:40 Rewilding vs Zoos 45:10 Tasmanian Tigers & Lost Species 52:00 Dr
Can we out-innovate extinction? In this captivating fireside chat from Monaco Day 2026 in Davos, Ben Lamm, CEO of Colossal Biosciences, joins moderator Tassos Economou to discuss the "Moon landing of biology." Beyond the headlines of woolly mammoths and dodos, Ben Lamm explores how de-extinction technology is being open-sourced to solve the modern biodiversity crisis and why we must replace "environmental doom and gloom" with scientific hope to inspire the next generation. Key Topics Discussed: -The De-extinction Toolkit: Why building a backup for nature is essential for global food and water security. -The BioVault Initiative: Creating international standards to preserve animal DNA, similar to plant seed vaults. -Science as Entertainment: The importance of making biology culturally relevant to engage kids and investors. -Economic Spinouts: How Colossal’s research is leading to breakthroughs in plastic degradation and computational biology (Form Bio). -The Dinosaur Question: A reality
Did you ever think you’d live to see woolly mammoths return? For Episode Five of Brave New World, Evgeny is joined by Ben Lamm, CEO and co-founder of the most forward thinking de-extinction company on the planet, Colossal Biosciences. Since Ben co-founded the Austin based biotech start-up with legendary geneticist George Church in 2021, Colossal has consistently made headlines with their Jurassic Park-esque breakthroughs. In this conversation, Ben goes into the science behind “bringing back” an extinct species, how sci-fi and speculative fiction has inspired Colossal’s work, and the incredible implications de-extinction could have for conservation and the planet. Episode breakdown 🧩 00:00 Intro 01:16 Colossal’s scope 02:36 How de-extinction works 06:20 Why dinosaurs are unrealistic 08:16 The mammoth challenge 13:06 Evgeny’s connection 23:00 Colossal’s timeline 25:30 Stranger than fiction 33:54 Getting into the science 41:14 Dire wolves 47:05 Conservation and rewilding 53:06 Meddlin
Axios national energy correspondent Amy Harder speaks to Colossal co-founder and CEO Ben Lamm at Axios House in Davos.
A colossal tsunami🌊 rises from the ocean, sending anthropomorphic animals running from the beach into the city. Just when the chaos peaks, the scene transforms into a game world—where Fox watches it all unfold. Surreal, cartoon-style storytelling blending disaster, escape, and gaming in one epic reel. Watch till the end for the twist! 🦊🐷 Hashtags: #Tsunami #CartoonShorts #AnimalsEscape #EpicTwist #MrHogger Call-to-action: “Did you catch the twist? Comment your reaction!” Music: ---------- Music: It's A Good Day Musician: Chris Mason (from Audiio)
In this debut episode of _Galaxy Balance_, host Cory Smith sits down with legendary geneticist and futurist George Church for a wide-ranging conversation on the edge of science and imagination. Together they explore the accelerating frontier of *AI-driven biology*, including protein design, scientific “superintelligence,” and the rise of automated science factories. 00:00 - Introduction to George Church and the frontier of exploration 01:30 - How AI accelerates discoveries in biology today 02:18 - The role of startups in protein design and AI's current impact 03:52 - Caution around artificial general intelligence versus narrow scientific AI 04:50 - The future of human-in-the-loop in biosafety and AI deployment 06:44 - Long-term visions for scientific superintelligence 08:50 - The potential of AI-driven science factories and automation in research 10:24 - What sets Lila.ai apart in AI and biology integration 12:49 - The concept of AI Science Factories and the future of automated labora
New Episode drops Thursdays @ 11am ET. No commercials/ads. To support the channel, Please Subscribe, Comment, Like, Share and turn the bell 🔔 ON for new episode notifications🙏🏼💜🙏🏼 In this episode, Colossal Biosciences CEO Ben Lamm breaks down how his team is using synthetic biology to revive extinct animals like the woolly mammoth, dire wolf, and dodo—and why de-extinction is ultimately about saving today’s endangered species. Ben shares how mentorship from George Church launched this mission, how AI is transforming conservation, why ecosystem restoration matters as much as the lab work, and how these technologies could shape life on Earth—and beyond—for generations to come. A fast-paced look into the future of species revival, biodiversity, and the evolving relationship between humanity, technology, and the natural world. Follow Matt Beall Limitless: https://x.com/MattbLimitless https://x.com/MBeallX https://www.tiktok.com/@mblimitless https://www.instagram.com/mattbealll
In this special episode of Robin’s Nest, we’re joined by Dr. George Church, a world-renowned geneticist and one of the leading minds behind the Human Genome Project, for a conversation about the amazing ways science is helping us understand, protect and even restore life on Earth. Dr. Church takes us inside the frontier of synthetic biology, from the origins of CRISPR and gene editing to the bold promise of de-extinction, conservation technology and genetic equity. The discussion spans his groundbreaking work with Colossal Biosciences, where efforts to revive the woolly mammoth and other lost species aim to restore ecosystems and rethink what “saving nature” means in the 21st century. Listeners will hear Dr. Church reflect on the ethics and responsibilities of rewriting life’s code, the potential for genetic engineering to combat biodiversity loss, and why he believes “extinction doesn’t have to be forever.” This episode explores how technology and conservation can work hand-in-hand
NOTE - Some viewers are seeing the podcast open in Hindi by default. To switch to the original audio: Settings → Audio Track → English Original. Welcome to PGX Ideas #2 Here I sit down with some of the most interesting minds in the world — scientists, philosophers, economists, and creators — to think about the forces shaping the future. Each episode is an attempt to understand ONE BIG question. The kind that doesn’t have a single answer but reveals how people who think deeply approach life, work, and meaning. This time, I spoke with Ben Lamm — Founder and CEO of Colossal Biosciences about: What will de-extinction lead to? Timestamps: 00:00 - What Is Colossal Doing? 01:30 - What is De-Extinction? 03:05 - Science Behind Artificial Wombs 21:07 - How did they de-extinct Direwolves? 32:01 - What other animals can return? 35:48 - Can we revive dinosaurs? 47:07 - Technologies changing the World 49:03 - What if Tech had no limits? 53:49 - Can we create entire new species? 58:34 - 3D-Prin
You’re not dreaming. 🐺 Colossal Biosciences — led by Ben Lamm — just pulled off the impossible: They used DNA from a 73,000-year-old skull and a 12,500-year-old tooth to create living direwolf puppies. What started as a myth is now a milestone. TIME Magazine’s cover story. Millions of views. Two direwolves now celebrating their first birthday — with a custom cake. This isn’t sci-fi. It’s the start of biotech resurrection. And Colossal isn’t stopping with direwolves. 🎙️ Full episode with Ben Lamm hosted by Reena Malyan — dropping soon. #ColossalBiosciences #BenLamm #Direwolves #DeExtinction #FutureTech #Biotech #SyntheticBiology #CRISPR #Genomics #Innovation #Longevity #AI #DNA #Colossal #AxionSocial #ReenaMalyan
Ben Lamm, co-founder of Colossal Biosciences, comes on the podcast to discuss their groundbreaking mission to bring back woolly mammoths by 2028. From AI-powered genome editing to artificial womb technology, Ben explains how Colossal is leveraging cutting-edge innovation to tackle biodiversity loss, conservation, and even develop vaccines for species like elephants. The conversation explores the role of AI in ancient DNA reconstruction, the impact of keystone species on ecosystems, and the ethical implications of de-extinction. Ben also shares fascinating insights into how Colossal's research is inspiring future generations and revolutionizing synthetic biology. Hear about the challenges of rewilding extinct species and the transformative potential of combining AI with future technologies like quantum computing. This episode is packed with bold ideas and inspiring discussions on how science and technology are reshaping the world. 💥 What You’ll Learn 👉 How Colossal Biosciences plans
In this episode, we are joined by Professor George Church (Harvard Medical School, Wyss Institute, Colossal Biosciences) – a pioneering scientist who helped launch the fields of genomics, synthetic biology, and genome engineering. We explore his revolutionary work on the Human Genome Project, CRISPR technology, and the future of de-extinction, aging reversal, co-founding companies and engineering life. From sequencing the first human genome to designing new species, George Church shares his bold vision for the future of biology, and humanity itself. What you’ll learn: • How George Church’s personal journey led to some of the biggest breakthroughs in Biology • Insight into the early days of genome sequencing and the Human Genome Project • How multiplex CRISPR-editing is reshaping medicine and biotechnology • Why synthetic biology is key to sustainability, de-extinction, and planetary health • The science and ethics behind engineering mammoths and reviving lost traits • How we might sl
Colossal Biosciences is a de-extinction company focused on leveraging advances in genetic engineering and reproductive technologies to bring back extinct species, with a current focus on the Dodo and the Moa. Its mission also extends to advancing biodiversity conservation for currently endangered species through the tools and knowledge developed for de-extinction projects. The company's work involves cutting-edge avian cellular science and genomics. Colossal Biosciences has announced an additional $120 million in funding, placing company's valuation at $10.32 billion. This capital, with participation from USIT, Bob Nelsen, and Peter Jackson, adds to its existing $200 million Series C, bringing the total for this funding round to $320 million. Since launching in September 2021, Colossal has now raised just over $555 million in total funding. Colossal Biosciences, headquartered in Austin, Texas, United States, was founded in 2021 by Ben Lamm, Andrew Busey, Brian Beard, George Church,
We’re definitely going to make more dire wolves. 🐺 🐺 🐺 🐺 🐺 We’re working toward a pack size of roughly 5 - 8, which would be similar to the average pack size in the wild. Watch Colossal Co-founder & CEO Ben Lamm on @TomBilyeu. SUBSCRIBE to follow our innovations: https://bit.ly/3KqNZAy About Colossal Biosciences: MAKING EXTINCTION A THING OF THE PAST. Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal Biosciences creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction. Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition throug
Dr. George Church, is a genetics professor at Harvard Medical School and the Wyss Institute. George is a pioneer in synthetic biology and personalized genomics. In 2017, Time magazine named him as one of the 100 most influential people in the world. In addition to being a scientist, George is also a prolific serial entrepreneur. He has co-founded over 50 biotech startups through his lab at Harvard. George also serves as a Faculty Advisor for the Harvard Biotech Club. In this episode, * George shares his career path to become a professor at Harvard Medical School and the Wyss Institute, where his lab focuses on various topics related to synthetic biology. * George discusses his work on developing genome sequencing methods during his PhD and its impact on the Human Genome Project. * George discusses the development of genome editing methods and how his lab and other pioneers developed CRISPR systems as a genome editing modality, and eventually co-founded Editas. * George refle
Colossal founder Ben Lamm on the process behind de-extinction #colossal #deextinction #mammoth #dinosaurs #fyp #hazardboys
What happens when humanity faces the sixth mass extinction event in Earth's history? Serial entrepreneur Ben Lamm believes we need a backup plan. With a track record of building and exiting companies across AI, gaming, and conversational intelligence, Ben took on his most audacious venture in 2021: co-founding Colossal Biosciences with Harvard geneticist Dr. George Church to bring extinct species back to life. The company has already successfully de-extincted the dire wolf and aims to return woolly mammoths to the Arctic by 2028. In this episode, Ben shares: * How his self-described "unemployable" streak became his entrepreneurial superpower * Why asking naive questions helps him tackle impossible challenges across industries * How Colossal's breakthrough technologies represent humanity's essential insurance policy for planetary survival.
Colossal Biosciences CEO & Co-Founder Ben Lamm on the plan to bring the South Island giant moa back from the dead. Subscribe and be notified of breaking news: https://goo.gl/LP45jX Check out our playlists: https://goo.gl/Swd249 NZ Herald Facebook: https://goo.gl/tUC4oq NZ Herald Instagram: https://goo.gl/oLicXe NZ Herald Twitter: https://goo.gl/Wi6mbv
Friend of Den of Geek, Ben Lamm (CEO of Colossal Biosciences) broke the internet with the Direwolf* de-extinction. It's pretty obvious he is into dinosaurs and the Jurassic Park franchise, so David asked Ben his review of the film, as well as updates on the wolf pups, the ongoing conservation efforts, and if it's at all possible to clone a dinosaur. *it's complicated —————————— Read more: https://www.denofgeek.com —————————— Follow Den of Geek: Website: https://www.denofgeek.com Twitch: https://www.twitch.tv/denofgeekTV Facebook: https://www.facebook.com/DenOfGeekUS Twitter: https://twitter.com/DenofGeekUS Instagram: https://www.instagram.com/denofgeek TikTok: https://www.tiktok.com/@denofgeektv —————————— By Experts. For Fans. The only thing better than watching, reading, or playing something you love is helping someone else discover it. Den of Geek is dedicated to serving the interests of today’s entertainment enthusiast. —————————— #colossalbiosciences #jurassicworldrebirth #direwo
Colossal’s Ben Lamm says we will have dinosaur equivalents within the next 100 years #dinosaurs #colossal #engineering #bioengineering #tech #fyp #hazardboys
❓Are we bringing back a saber-toothed tiger? Colossal Co-Founder and CEO Ben Lamm says, “…there is great Homotherium DNA.” Homotherium was a scimitar-toothed cat that lived during the Pleistocene. Confirmed: no. Fun to think about: absolutely. SUBSCRIBE to follow our innovations: https://bit.ly/3KqNZAy About Colossal Biosciences: MAKING EXTINCTION A THING OF THE PAST. Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal Biosciences creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction. Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condi
🛎 If You're New Subscribe ► https://bit.ly/BtBSubscribe Part Two: Dire Wolves, Dr. George Church & The De-Extinction Grift | BEHIND THE BASTARDS Robert explores Dr. Church's weird history with eugenics adjacent projects, like the world's creepiest dating app, and how Colossal Biosciences was created and immediately used by the Trump administration as an excuse to attack the Endangered Species Act. Original Air Date: June 5, 2025 ❤️ iHeartRadio » https://ihr.fm/3D75eCI 📢 APPLE PODCASTS » https://apple.co/3FnuPKg 📢 AMAZON MUSIC » https://amzn.to/3fgTxla 🟢 SPOTIFY » https://spoti.fi/3SXCwtQ 🎥 PREVIOUS VIDEO » https://youtu.be/N7f7kFrFMXc 👕 GRAB YOUR MERCH » https://bit.ly/3U4npQo ✨ KEEP IN TOUCH WITH : TWITTER » https://bit.ly/3Nbw2q7 INSTAGRAM » https://bit.ly/3WdrQua There’s a reason the History Channel has produced hundreds of documentaries about Hitler but only a few about Dwight D. Eisenhower. Bad guys (and gals) are eternally fascinating. Behind the Bastards dives in
🛎 If You're New Subscribe ► https://bit.ly/BtBSubscribe Part One: Dire Wolves, Dr. George Church & The De-Extinction Grift | BEHIND THE BASTARDS Robert walks Langston Kerman through the story of Dr. George Church, a very real scientist who co founded the company making bullshit claims of "de extincting" dire wolves. (2 Part Series) Sources: George Church, Colossal W*nker – For Better Science - https://forbetterscience.com/2023/06/26/george-church-colossal-wnker/ Can Gene Therapy Slow Ageing in Dogs? - Gowing Life - https://www.gowinglife.com/can-gene-therapy-slow-ageing-in-dogs/ Never-ageing Anti-aging to cure COVID-19 – For Better Science - https://forbetterscience.com/2020/05/14/never-ageing-anti-aging-to-cure-covid-19/ The original sins of Leonard Guarente – For Better Science - https://forbetterscience.com/2023/04/17/the-original-sins-of-leonard-guarente/ Jeffrey Epstein Hoped to Seed Human Race With His DNA - The New York Times - https://www.nytimes.com/2019/07/31/business/j
iTrust Capital: Use code IMPACTGO when you sign up and fund your account to get a $100 bonus at https://impacttheory.co/iTrustCapitalMay Shopify: Sign up for your one-dollar-per-month trial period at https://impacttheory.co/ShopifyApr On this mind-bending episode of Impact Theory, Tom Bilyeu sits down with Ben Lamm, the visionary entrepreneur behind Colossal Biosciences, to explore a world that sounds straight out of science fiction—yet is rapidly becoming our reality. Together, they pull back the curtain on the groundbreaking technology making de-extinction not only possible, but increasingly practical, from resurrecting woolly mammoths and dire wolves to saving endangered species and unraveling the secrets of longevity. Ben explains how CRISPR gene editing has unlocked the power to make precise DNA changes—editing multiple genes simultaneously, synthesizing entirely new genetic blocks, and pushing the limits of what's possible in biology and conservation. The conversation dives dee
What if aging was optional—and extinction reversible? In this episode of Ignition Sequence, geneticist and biotech pioneer Dr. George Church joins host Dylan Bohbot to explore the frontiers of gene therapy, de-extinction, and the future of human health. A founding scientist behind the Human Genome Project, and co-founder of Colossal Biosciences and Rejuvenate Bio, Dr. Church breaks down the science behind living longer, reviving extinct species like the woolly mammoth and dire wolf, and using synthetic biology to heal ecosystems—and ourselves. The conversation spans decades of innovation, from the earliest genome sequencing breakthroughs to today’s radically affordable, precision therapies. Along the way, Dr. Church shares compelling stories, surprising stats, and visionary goals for how gene editing and de-extinction might actually reverse climate change and extend the healthy human lifespan well beyond 100. In this episode, you’ll learn: 1. Why George Church believes there’s no bio
@joerogan: "So…you started a de-extinction company? How exactly does one get started doing that?" Colossal Co-Founder and CEO Ben Lamm shares the origin story behind the world’s first de-extinction and species preservation company. SUBSCRIBE to follow our innovations: https://bit.ly/3KqNZAy About Colossal Biosciences: MAKING EXTINCTION A THING OF THE PAST. Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal Biosciences creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction. Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through
WATCH REACTION EPISODE ON PATREON: https://www.patreon.com/JulianDorey (***TIMESTAMPS in description below) ~ Ben Lamm is an American serial entrepreneur & billionaire. He is best known for founding Colossal Biosciences with Harvard Geneticist George Church. Colossal utilizes genetic engineering and reproductive technology to attempt the de-extinction of extinct species. They recently recreated genetically modified dire wolves and seek to re-create the Woolly Mammoth in the next 5 years. Matt James is an exotic animal expert, zoologist & Chief Animal Officer of Colossal Biosciences. BEN & MATT's LINKS - Ben IG: https://www.instagram.com/benlamm/?hl=en - Ben X: https://x.com/benlamm?lang=en - Matt IG: https://www.instagram.com/m_walkerj/?locale=en_AE%2B2&hl=en - Colossal YT: @Colossal - Colossal Website: https://colossal.com/ FOLLOW JULIAN DOREY INSTAGRAM (Podcast): https://www.instagram.com/juliandoreypodcast/ INSTAGRAM (Personal): https://www.instagram.com/julianddorey/ X: h
Ben Lamm, co-founder and CEO of Colossal Biosciences, joins "Elizabeth Vargas Reports" to discuss his lab's work creating dire wolves and the possibility of bringing back other extinct species. #DireWolves #Animals #Science Anchor Elizabeth Vargas delivers the biggest stories, without bias or opinion. Watch "Elizabeth Vargas Reports" every weeknight at 7p/6C on NewsNation. #VargasReports NewsNation is your source for fact-based, unbiased news for all Americans. More from NewsNation: https://www.newsnationnow.com/ Get our app: https://trib.al/TBXgYpp Find us on cable: https://trib.al/YDOpGyG How to watch on TV or streaming: https://trib.al/Vu0Ikij
In this episode, Ben, Salim, and Peter discuss the Dire Wolf breakthrough, which animals Colossal will be bringing back from extinction, and setting the record straight. Recorded on April 15th, 2025 Views are my own thoughts; not Financial, Medical, or Legal Advice. Ben Lamm is a serial entrepreneur and the co-founder and CEO of Colossal Biosciences, a company leading the de-extinction movement through advanced gene-editing technologies recently valued at over $10B. He previously founded several successful tech ventures including Chaotic Moon Studios, Conversable, and Hypergiant Industries, with a focus on AI, biotechnology, and space. Salim Ismail is a serial entrepreneur and technology strategist well known for his expertise in Exponential organizations. He is the Founding Executive Director of Singularity University and the founder and chairman of ExO Works and OpenExO. Learn more about Colossal Biosciences: https://colossal.com/ Join Salim's upcoming workshop on building an
De-extinction is just the beginning. Pioneered by George Church and Ben Lamm, Colossal’s tech-driven approach is reshaping conservation, species preservation, and even human health. It’s why visionaries like Tony Robbins are backing the mission. SUBSCRIBE: https://bit.ly/3KqNZAy Follow Colossal: Instagram: https://www.instagram.com/itiscolossal/ X: https://twitter.com/colossal Facebook: https://www.facebook.com/itiscolossal LinkedIn: https://www.linkedin.com/company/itiscolossal About Colossal Biosciences: MAKING EXTINCTION A THING OF THE PAST. Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal Biosciences creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of specie
This week marked a major scientific breakthrough: the resurrection of the dire wolf, a species that went extinct over 12,000 years ago. A Dallas-based biotech company, Colossal Biosciences, is behind the project and Walter Isaacson speaks to its co-founder, Harvard University geneticist George Church. Originally aired on April 11, 2025 ---------------------------------------------------------------------------------------------------------------------------------------- Major support for Amanpour and Company is provided by Jim Attwood and Leslie Williams, Candace King Weir, the Sylvia A. and Simon B. Poyta Programming Endowment to Fight Antisemitism, the Leila and Mickey Straus Family Charitable Trust, Mark J. Blechner, the Filomen M. D’Agostino Foundation, Seton J. Melvin, the Peter G. Peterson and Joan Ganz Cooney Fund, Charles Rosenblum, Koo and Patricia Yuen, Barbara Hope Zuckerberg, and Jeffrey Katz and Beth Rogers. Subscribe to the Amanpour and Company channel here: https://b
In the words of @joerogan : “You made a f*ing dire wolf.” Actually, we made three. Romulus, Remus, and Khaleesi made their debut for the world this week, and caught an appearance on “The Joe Rogan Experience” with our Co-Founder and CEO Ben Lamm. SUBSCRIBE: https://bit.ly/3KqNZAy Follow Colossal: Instagram: https://www.instagram.com/itiscolossal/ X: https://twitter.com/colossal Facebook: https://www.facebook.com/itiscolossal LinkedIn: https://www.linkedin.com/company/itiscolossal About Colossal Biosciences: MAKING EXTINCTION A THING OF THE PAST. Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal Biosciences creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of spec
Desextinção: espécie de lobos de 'Game of thrones' volta à vida após 10 mil anos Uma empresa de biotecnologia conseguiu criar três animais da espécie "lobo terrível". A filhote mais nova, que tem três meses de idade, foi batizada de Khaleesi, em homenagem à personagem de 'Game of Thrones' De acordo com a empresa, os primeiros exemplares da espécie renascida nasceram em outubro de 2024. São dois machos, batizados de Remus e Romulus, em referência aos irmãos fundadores de Roma Divulgação/Colossal Biosciences Cientistas de uma empresa norte-americana de biotecnologia, a Colossal Biosciences, trouxeram de volta à vida uma espécie de lobo extinta há mais de 10 mil anos, os lobos terríveis — espécie que ficou famosa pela série de televisão Game of Thrones. As informações a respeito desse feito inédito foram divulgadas nesta segunda-feira (7/4). De acordo com a empresa, os primeiros exemplares da espécie renascida nasceram em outubro de 2024. São dois machos, batizados de Remus e Romulus, em
Ben Lamm is a serial entrepreneur and the founder and CEO of Colossal Biosciences, a company dedicated to genetic engineering and de-extinction projects. Colossal’s mission includes bringing back extinct species like the woolly mammoth and advancing conservation efforts through cutting-edge biotechnology. https://www.colossal.com
Colossal CEO Ben Lamm says humanity has a ‘moral obligation’ to pursue #shorts #colossal #obligation
At Colossal Biosciences, we endeavor to jumpstart nature’s ancestral heartbeat. But our mission extends beyond science—we’re equally passionate about jumpstarting and empowering the next generation of innovators. Recently, we had the privilege of welcoming David, a young future scientist, for a tour and immersive exploration of our woolly mammoth de-extinction lab in Texas. A heartfelt thank you to @TonyRobbinsLive for hosting Colossal Co-founder & CEO Ben Lamm and for helping us ignite David’s passion for the work we do. SUBSCRIBE: https://bit.ly/3KqNZAy Follow Colossal: Instagram: https://www.instagram.com/itiscolossal/ X: https://twitter.com/colossal Facebook: https://www.facebook.com/itiscolossal LinkedIn: https://www.linkedin.com/company/itiscolossal About Colossal Biosciences: MAKING EXTINCTION A THING OF THE PAST. Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal Biosci
This is the largest investment ever in species preservation, putting Colossal alongside companies like SpaceX and OpenAI. Scientists predict that we could lose up to 50% of all species on earth in the next 25 years. We're not going to stand by and let that happen. Follow along on our mission to make extinction a thing of the past 🧬🚀 SUBSCRIBE: https://bit.ly/3KqNZAy Follow Colossal: Instagram: https://www.instagram.com/itiscolossal/ X: https://twitter.com/colossal Facebook: https://www.facebook.com/itiscolossal LinkedIn: https://www.linkedin.com/company/itiscolossal About Colossal Biosciences: MAKING EXTINCTION A THING OF THE PAST. Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal Biosciences creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of
Karl and Erum welcome Dr. Chris Mason. He’s a professor of genomics, physiology, and biophysics, as well as co-founder / COI of BiotiaNYC, Ursa Bio, and Onegevity. Chris will take you on a journey from the mysteries of space genomics to the hidden worlds of Earth's microbiomes. He discusses the intersection of advanced biology and space exploration, diving into his work with NASA’s twin study, the possibilities of planetary engineering, and his fascination with unknown DNA found even in urban subways. Chris also talks about how the convergence of ancient biological knowledge and cutting-edge technology could redefine humanity's future, both on Earth and beyond. Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing? Learn more at www.messaginglab.com/groweverything (
In this very special live taping of 'The Dish', Johannes sits down with renowned geneticist, George Church. Widely known for discovering the first direct genomic sequencing method, Church has reshaped the world of genetics. A professor at Harvard and MIT and a founding professor at the Wyss Institute, Church has co-founded over 50 startups—15+ of which have resided at LabCentral. George Church's more recent work at Colossal Biosciences centers on de-extinction, aiming to bring back species like the woolly mammoth. In this episode Johannes and George cover demystifying GMOs, the ethics of biotech, resurrecting woolly mammoths, and kickstarting over 50 startups. Tune for a fascinating conversation on innovation, entrepreneurship, and the future of biotech! 📌 Timestamps: 00:00:47 Introduction 00:02:17 Woolly mammoths & de-extinction 00:05:47 Xenotransplantation 00:08:12 GMOs & bioethics 00:17:10 AI in biotech 00:21:56 Future of biotech 00:27:36 Genetic engineering & climate change
SUBSCRIBE: https://bit.ly/3KqNZAy Follow Colossal: Instagram: https://www.instagram.com/itiscolossal/ X: https://twitter.com/colossal Facebook: https://www.facebook.com/itiscolossal LinkedIn: https://www.linkedin.com/company/itiscolossal About Colossal Biosciences: MAKING EXTINCTION A THING OF THE PAST. Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal Biosciences creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction, beginning with the woolly mammoth. Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through cutting-edge sci
In this episode, Anthony talks to Dr. George Church. Dr. Church is a Robert Winthrop Professor of Genetics at Harvard Medical School, Professor of Health Sciences and Technology at Harvard University and Massachusetts Institute of Technology (MIT), and founding Core Faculty member of the Wyss Institute for Biologically Inspired Engineering at Harvard University. He received his PhD in biochemistry and molecular biology at Harvard University in 1984. His research has spanned many disciplines, from genomic sequencing to synthetic biology. He has also co-founded multiple companies, such as Colossal Biosciences, which is working to de-extinct various species like the woolly mammoth. If you want to know more about the research discussed in this episode or about the Genetics program at Texas A&M, please visit the following websites: Dr. Church’s bio from the Wyss Institute: https://wyss.harvard.edu/team/core-faculty/george-church/ George Church’s Google Scholar: https://scholar.google.co
Listen in on this groundbreaking discussion on the cutting-edge field of de-extinction, where visionary entrepreneur and CEO of Colossal Biosciences, Ben Lamm, pushes the boundaries of biotechnology to bring extinct species like the woolly mammoth back to life. In a thought-provoking conversation moderated by Erik J Anderson, Founder and CEO of WestRiver Group and CEO and Chairman of Singularity Group, Ben Lamm delves into the scientific advancements and ethical considerations surrounding de-extinction. Explore the potentially world altering impact of this revolutionary work on the future of conservation and discover how it could forever alter our understanding of the natural world. This talk was recorded at Summit At Sea in April 2024. Interested in joining Summit Membership or attending a Summit flagship event? Apply at https://summit.co/join. Connect with Summit: https://summit.co https://instagram.com/summit https://fb.com/summit About Summit Summit is an ecosystem that exi
Hear it from our Co-founder and CEO, @Ben Lamm, who discussed at the Future of Everything Festival, hosted by @WSJ. Explore our work with the Woolly Mammoth and its significance for biodiversity. 🦣 SUBSCRIBE: https://bit.ly/3KqNZAy Follow Colossal: Instagram: https://www.instagram.com/itiscolossal X: https://twitter.com/itiscolossal Facebook: https://www.facebook.com/itiscolossal LinkedIn: https://www.linkedin.com/company/itiscolossal About Colossal Biosciences: MAKING EXTINCTION A THING OF THE PAST. Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal Biosciences creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction, beginning with the woolly
Ben Lamm and George Church are co-founders of Colossal, a bioscience and genetics company that will rapidly advance the field of species de-extinction. Ben is CEO, and is a serial technology entrepreneur driven to solve the most complex challenges facing our planet. Dr. Church is Colossal's lead genetic advisor and the recognized leader in genomics, pioneering a number of advances and breakthroughs that have progressed the entire field. Colossal Biosciences (https://colossal.com) A Case for De-Extinction | Ben Lamm & Eriona Hysolli at SXSW 2022 (https://youtu.be/B79bdjig1Mo) - YouTube Siberia’s Pleistocene Park: Bringing Back Pieces of the Ice Age to Combat Climate Change (https://youtu.be/nEzskUGJ_1I) - 60 Minutes Saving Baby Elephants from a Deadly Herpes Virus (https://www.discovery.com/science/elephant-vaccine) - Discovery Form Bio Spins Out of Colossal Bioscience to Offer Scientists the ‘Missing Piece’ (https://dallasinnovates.com/with-30m-in-funding-form-bio-spins-o
Summary: In this episode, we are excited to welcome Dr. George Church, Professor at Harvard Medical School and MIT, and Co-founder of Eugit Therapeutics, Colossal Biosciences, Arrived AI, and eGenesis. He is also the Director of PersonalGenomes.org, the world's only open-access information hub for human genomic, environmental, and trait data, as well as an IARPA BRAIN Project and the NIH Center for Excellence in Genomic Science. If that weren’t enough, George was named one of the 100 most influential people in the world in Time Magazine’s 2017 Time 100 list. In 2022, he was featured among the most influential people in biopharma by FiercePharma, where he was listed among the top 8 most famous geneticists in human history. All to say, you won’t want to miss this episode with a genetics superstar! Show Notes: 0:00 Introduction 1:00 George’s upcoming big projects, including developing full recycling, renewing energy, creating bioweather maps, and harnessing citizen science 6:45 Pr
Colossal Biosciences believes bringing back the woolly mammoth will help fight climate change. Ben Lamm, CEO of Colossal Biosciences, discusses how Colossal is using CRISPR and other gene-editing technologies to “de-extinct” species that have been wiped from the earth. Record Date - 9/25/23
Explore the unseen world of DNA: Chris Mason, professor of genomics, physiology, and biophysics at Weill Cornell Medicine, sheds light on sequencing ancient biology to better understand organisms and ecosystems today. SUBSCRIBE: https://bit.ly/3KqNZAy Follow Colossal: Instagram: https://www.instagram.com/itiscolossal Twitter: https://twitter.com/itiscolossal Facebook: https://www.facebook.com/itiscolossal LinkedIn: https://www.linkedin.com/company/itis... About Colossal Biosciences: THE SCIENCE OF GENETICS. THE BUSINESS OF DISCOVERY. Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal Biosciences creates disruptive technologies for extinct species restoration, critically endangered species protection, and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction, beg
Unlock the code of life with Dr. Chris Mason, professor of genomics, physiology, and biophysics at Weill Cornell Medicine, as he expresses his vision for empowering genetic science to improve life on Earth. SUBSCRIBE: https://bit.ly/3KqNZAy Follow Colossal: Instagram: https://www.instagram.com/itiscolossal Twitter: https://twitter.com/itiscolossal Facebook: https://www.facebook.com/itiscolossal LinkedIn: https://www.linkedin.com/company/itis... About Colossal Biosciences: THE SCIENCE OF GENETICS. THE BUSINESS OF DISCOVERY. Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal Biosciences creates disruptive technologies for extinct species restoration, critically endangered species protection, and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction, beginning wit
Ben Lamm is an entrepreneur, CEO of Colossal and a founder. What if Jurassic Park's dream of bringing extinct creatures back to life was possible? Well it kind of is. And Ben's company is forging ahead in the new frontier of de-extinction, starting with some of the most legendary animals from history. Expect to learn why Ben is bringing Wooly Mammoths back to life, how you give birth to an animal that died out thousands of years ago, where Ben gets the genetic material from, how bringing back Mammoths could fix climate change, whether artificial wombs will actually work, if we can make humans as strong as Neanderthals using their DNA, why we should bring back the Dodo bird and much more... Sponsors: Get the Whoop 4.0 for free and get your first month for free at https://join.whoop.com/modernwisdom (discount automatically applied) Get 5 Free Travel Packs, Free Liquid Vitamin D and more from AG1 at https://drinkag1.com/modernwisdom (discount automatically applied) Get 15% discount o
In this episode of Oh Ship, Freddie sits down with Ben Lamm, an extraordinary entrepreneur on a mission to save the planet. Delve into Ben's remarkable journey, from his successful tech exits to his current ventures at the forefront of bioscience and genetic engineering. Explore the intersection of entrepreneurship and global impact as Ben shares his insights on addressing critical issues, the responsible use of cutting-edge technologies, and the power of collaboration in driving positive change. #ohshipshow #EntrepreneurshipForGood #GlobalImpact #InnovationWithPurpose #CreatingChange
This episode is supported by exceptional companies: Experience the future of sleep with Eight Sleep. Visit https://www.eightsleep.com/moonshots/ to save $150 on the Pod Cover In this episode, Peter and Ben discuss the possibility of bringing extinct species back to life through Ben’s startup, Colossal. Ben Lamm is a renowned entrepreneur and visionary in technology and AI. With successful startups like Chaotic Moon Studios and Conversable, he has made significant contributions to the industry. As the founder of Hypergiant Industries and Colossal, a venture capital-backed startup focused on genetic engineering and reproductive technology in support of George Church's de-extinction efforts, Lamm continues to push the boundaries of innovation, focusing on AI solutions and genetic engineering. Learn about Colossal: https://colossal.com/ Topics: 0:00 Reviving Extinct Species with Tech 1:28 Ben Lamb: Take a Moonshot 2:05 De Extinction: Unveiling Our Future 3:06 Bringing Back Extinct
He is widely liked and respected by his colleagues: his life story of arriving in the UK as a child, not speaking English, rising to become a multi millionaire and a cabinet minister. But what was increasingly striking is almost all the Conservative MPs and ministers I spoke to privately would say this, and then add a colossal "but." Stay informed and stay ahead of the game with our daily news updates. Our team of experienced journalists brings you the latest and most relevant news from around the world, covering politics, business, technology, and more. We deliver unbiased and accurate reporting that you can trust. Never miss a beat with our daily news coverage. Stay informed and stay ahead of the game with our Today's News videos on YouTube. Keep up to date with the latest happenings in the world of news with just one click. Join a community of like-minded individuals who value staying informed. Be a part of something bigger and make a difference by donating to our PayPal account.
Featured Session: A Colossal Mission: A Case for De-Extinction New technological advancements make de-extinction possible – but should we do it? What if the rewilding of critical extinct species, as proxies to their original habitats, could help restore lost ecosystems and combat the effects of climate change? At Colossal, a team of world-renowned genetic scientists are using breakthrough advances in CRISPR technology to pioneer a practical and working model of animal de-extinction, beginning with the restoration of the Woolly Mammoth to the Arctic Tundra. Watch the featured session moderated by Richard Garriott with Colossal CEO Ben Lamm and Head of Biological Sciences Eriona Hysolli for a deep-dive look into the science and opportunities behind species restoration and a groundbreaking new approach to conservation. SUBSCRIBE: https://bit.ly/3KqNZAy Follow Colossal: Instagram: https://www.instagram.com/itiscolossal Twitter: https://twitter.com/itiscolossal Facebook: https://www.face
For fundamental-driven investment research on stocks as well as crypto, please join https://www.SumZero.com. For more on Colossal's work, check out https://www.colossal.com. 00:00 Start 00:10 Introduction: Divya Narendra 01:35 Introduction - George Church on Colossal’s goal of de-extincting genes 02:44 Why the Woolly Mammoth? 03:32 Mammoth most likely to make impact on currently sequestered carbon while resequestering carbon to pre-industrial levels 04:19 Pre-industrial ecosystems 05:13 Timeline on first mammoth(s). Ben Lamm 06:05 Genetic differences between mammoths and elephants 06:50 New Arctic elephants will be mammoth/Asian elephant hybrids 07:26 Mammoth project will also help save Asian and African elephants 07:50 CRISPR in pre-clinical trials for transplant organs 09:06 Probable mammoth-like phenotype expressions in Arctic elephants 10:19 Size range of ancient elephants, mammoths, and modern elephants 11:05 Relative ease of size and growth rate manipulation 12:08 Number of m
Les dernières avancées en ingénierie génétique poussent de nombreux scientifiques à étudier le processus de "dé-extinction". Mais quelles pourraient être les conséquences du retour d'espèces disparues en allant à l'encontre de la nature ? On en parle avec notre invitée, Laetitia Garriott de Cayeux, qui vient d'investir dans le projet de la start-up américaine Colossal, qui veut ramener à la vie le mammouth laineux. 🔔 Abonnez-vous à notre chaîne sur YouTube : https://f24.my/YTfr 🔴 En DIRECT - Suivez FRANCE 24 ici : https://f24.my/YTliveFR 🌍 Retrouvez toute l’actualité internationale sur notre site : https://www.france24.com/fr/ Rejoignez-nous sur Facebook : https://f24.my/FBvideos Suivez-nous sur Twitter : https://f24.my/TWvideos Découvrez l’actu en images sur Instagram: https://f24.my/IGfr
“It’s never going to be possible... - University of Georgia Facebook Вход Публикация University of Georgia University of Georgia Подтвержденный аккаунт 21 июль 2025 г. · Поделился/-ась с Доступно всем “It’s never going to be possible to bring something back that is 100% identical in every way to a species that used to be alive ... [but we can] create versions of extinct species that can help to make present-day ecosystems more robust, more resilient in the face of whatever it is that we’re going to throw at them in the next 5,000 years.” Have you seen news coverage the last few months about th
What a colossal production for the World Cup half-time show—pure magic, unlike anything I’ve ever seen on a cricket field. It felt almost like halftime at the Super Bowl. I wish this were televised for the world to enjoy, instead of just being for the spectators on the field. | Ganesh Krishnamurthy
Instagram Instagram Log In Sign Up Close Never miss a post from lilren1st Sign up for Instagram to stay in the loop. Sign up Log in Audio is muted lilren1st • Follow More options lilren1st Edited • 6w THIS SHI COLOSSAL ALL GAS NO BRAKES ALL 2026 🖤 FREE DA 10‼️ NEW EVERYTHING OTW💯 #imworking🤑 #explorepage✨ #fyp #mobbatlanta🌆 Load more comments 1stentmusic 2w 🖤🅿️ Like Reply drastickash 5w 🖤🖤 Like Reply falcon_records__ Verified 5w Awsm🩷hit in 📥📈 Like Reply rpmharlem 5w 🚀💫🚀💫 Like Reply cellyvisionz_ Verified 5w Dm me💰 Like Reply cxzacoriaaa 5w Woah💚 1 like Reply 101franxe 5w 🖤🖤
The Colossal Endeavor: Unveiling the Future of De-Extinction with Ben Lamm — BB&R Wellness Consulting Cart 0 Home Podcast Gasparilla Conference Blog Recipes Shop About Subscribe + Gift Back About Podcast Request In the Media Testimonials Cart 0 Home Podcast Gasparilla Conference Blog Recipes Shop About About Podcast Request In the Media Testimonials Bright Bold & Real Subscribe + Gift The Colossal Endeavor: Unveiling the Future of De-Extinction with Ben Lamm Join hosts Doro and Tricia as they delve into the groundbreaking world of de-extinction with their special guest, Ben Lamm,
Ben Lamm on Goals of Colossal Biosciences | Unscriptify Podcast - YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
Colossal Biosciences Acquires Viagen, the Leader in Animal Cloning - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Pres … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Colossal Biosciences Acquires Viagen, the Leader in Animal Cloning November 5, 2025 | 6 min read Twitter LinkedIn Facebook Email Print Acquisition furthers Colossal’s De-extinction and Species Preservation Platform with Viagen’s Proprietary Cloning, Cryopreservation, and Reanimation Technologies DALLAS--( … pertise and cloning technology stack have become the world’s standard and their application of these critical and proprietary technologies to endangered species conservation makes them an invaluable partner in advancing our global de-extinction and species preservation mission.” Founded in Austin, Texas in 2002, Viagen has grown from a livestock and genetic preservation company into the global leader in animal reproduction and preservation services for pets, equine, livestock … “Partnering with Colossal Biosciences presents an extraordinary opportunity to apply our advanced cryopreservation and cloning techniques to the ambitious goals of de-extinction and species restoration. Colossal’s innovative approach aligns with our mission to preserve genetic diversity and support conservation efforts globally. We are excited to see how this collaboration can advance science globally.” In 2022, Viagen expanded beyond cloning into advanced reproductive techn … icist and serial biotech entrepreneur George Church, Ph.D., and is the first to apply CRISPR technology for the purposes of species de-extinction. Colossal creates innovative technologies for species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. Co
Ozzy Osbourne’s Genome | MIT Technology Review You need to enable JavaScript to view this site. Skip to Content MIT Technology Review Featured Topics Newsletters Events Audio MIT Technology Review Featured Topics Newsletters Events Audio Biotechnology and health Ozzy Osbourne’s Genome Genome sequencing makes its move into pop culture. By Emily Singer archive page October 25, 2010 The “Godfather of heavy metal,” “the Prince of Darkness,” the man who made himself famous by biting the heads off small animals–Ozzy Osbourne–has had his genome sequenced. The former frontman for Black Sabbath and rea
Colossal launches with $15 million to bring back woolly mammoths | STAT Skip to Main Content Cancer ASCO FDA Newsletters Log In My Account Subscribe Now My Account Settings Complete your personal information for a more tailored experience Billing Log Out A decade of reporting from the frontiers of health and medicine Newsletters Log In My Account Subscribe Now Biotech Pharma Public Health Health Tech Policy Science First Opinion STAT+ STAT@ASCO Search Log In Try STAT+ My Account Home News Latest STAT10 Business Biotech Pharma Health Tech Health Insurance Hospitals Medical Devices Washington Po … cial linkedin.com/in/meganmolteni/ Tags biotechnology CRISPR ethics genetics To submit a correction request, please visit our Contact Us page . Trending For prostate cancer patients set on surgery, new hormone… For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study finds Revolution Medicines starts shipping experimental pancreatic cancer drug Revolution Medicines starts shipping experimental pancreatic cancer drug It’s the end of s
Colossal Biosciences Secures $150M Series B and Announces Plan to De-Extinct the Iconic Dodo - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Th … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Lone Star Bio Colossal Biosciences Secures $150M Series B and Announces Plan to De-Extinct the Iconic Dodo January 31, 2023 | 8 min read Twitter LinkedIn Facebook Email Print Colossal Biosciences, the world’s first de-extinction company, has today announced an oversubscribed $150M Series B financing led by United States … rsubscribed $150M Series B financing led by United States Innovative Technology Fund (“USIT”), with participation from Breyer Capital, WestRiver Group, Bob Nelsen, Animal Capital, Victor Vescovo, In-Q-Tel, Animoca Brands, Peak 6, BOLD Capital, and Jazz Ventures, among others. Following massive progress on the Woolly Mammoth and Tasmanian tiger, Colossal launches Avian Genomics Group to continue groundbreaking de-extinction pursuits DALLAS--( BUSINESS WIRE … rsubscribed $150M Series B financing led by United States Innovative Technology Fund (“USIT”), with participation from Breyer Capital, WestRiver Group, Bob Nelsen, Animal Capital, Victor Vescovo, In-Q-Tel, Animoca Brands, Peak 6, BOLD Capital, and Jazz Ventures, among others. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230131005411/en/ Dr. Beth Shapiro, Ph.D. (Lead Paleogeneticist and Colossal Scientific Advisor … ations to de-extinction, conservation and human healthcare. “The World Wildlife Fund found that in the last 50 years, Earth’s wildlife populations have plunged by an average of 69% at the hands of mankind,” said Ben Lamm, co-founder and CEO of Colossal. “By gathering the smartest minds across investing, genomics, conservation and synthetic biolog
The Colossal Foundation Donates $1.5M to the Wyss Institute at Harvard University to Advance Artificial Womb Technology for Wildlife Conservation - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Man … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases The Colossal Foundation Donates $1.5M to the Wyss Institute at Harvard University to Advance Artificial Womb Technology for Wildlife Conservation January 13, 2025 | 5 min read Twitter LinkedIn Facebook Email Print Novel scientific research will support the development of cutting-edge animal reproductive t … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
World-Leading Developmental Biologist Andrew Pask, Ph.D Joins Colossal Full-time as Chief Biology Officer - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cel … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases World-Leading Developmental Biologist Andrew Pask, Ph.D Joins Colossal Full-time as Chief Biology Officer August 21, 2025 | 5 min read Twitter LinkedIn Facebook Email Print Colossal Biosciences Initiates Colossal Australia at the University of Melbourne expanding Colossal’s presence in Australia and beyon … orefront of de-extinction research, not just to bring back lost species, but to apply those technologies in real-time to save those still with us." Pask’s work has redefined how scientists understand and protect Australia’s unique and endangered fauna. He has received international acclaim for his contributions to marsupial biology, including understanding their evolution and adaptation, and is one of the pioneers of de-extinction technologies. With more than two decades of e … nd Medical Research Council Fellowships, the Australian Research Council Future Fellowship, and the University of Melbourne’s flagship R@MAP Fellowship. Pask is also an Emerging Researcher Award recipient in the U.S., a Fellow of the Society for Reproductive Biology, and winner of the University of Melbourne’s top two research awards. Pask brings to Colossal a track record of innovation, collaboration, and mentorship that will help the scientific team reach audacious goals. “ … icist and serial biotech entrepreneur George Church, Ph.D., and is the first to apply CRISPR technology for the purposes of species de-extinction. Colossal creates innovative technologies for species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. Co
Colossal Secures $200M in Series C Funding From TWG Global on the Back of Numerous World’s First Scientific Breakthroughs on Path to De-Extinction - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Ma … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Colossal Secures $200M in Series C Funding From TWG Global on the Back of Numerous World’s First Scientific Breakthroughs on Path to De-Extinction January 15, 2025 | 18 min read Twitter LinkedIn Facebook Email Print Funding allows for expansion of labs, teams, and additional species candidates for de-exti … ation was launched, a sister 501(c)(3) focused on overseeing the deployment and application of Colossal-developed science and technology innovations. The organization currently supports 48 conservation partners and their global initiatives around the world. This includes partners like Re:wild, Save The Elephants, Biorescue, Birdlife International, Conservation Nation, Sezarc, Mauritian Wildlife Foundation, Aussie Ark, International Elephant Foundation, and Saving Animals From … ies. The real promise lies not just in the technology, but also in how we might apply these tools to protect and restore endangered species and ecosystems.” The breakthroughs in Colossal’s core projects create a ripple effect across species conservation. Each Colossal core species is tied to conservation efforts that support other endangered and at-risk species in the respective animal’s family group. The company’s work toward mammoth restoration has simultaneously advanced r … xonomic families. Key initiatives include: Colossal’s $7.5M in new donations to fund ancient DNA research across a diverse selection of species; The development of a gene-engineering solution to create cane toad toxin resistance for Australia’s endangered northern quoll; A partnership with the international conservation organization Re:wild on a
Game of clones: Colossal's new wolves are cute but are they dire? | MIT Technology Review You need to enable JavaScript to view this site. Skip to Content MIT Technology Review Featured Topics Newsletters Events Audio MIT Technology Review Featured Topics Newsletters Events Audio Biotechnology and health Game of clones: Colossal’s new wolves are cute, but are they dire? Colossal Biosciences claims it has revived an extinct species, but scientists outside the company are skeptical. By Antonio Regalado archive page April 8, 2025 Andrew Zuckerman/Colossal Biosciences Somewhere in the norther
Colossal Achieves Multiple Scientific Firsts in Progress Towards Thylacine De-Extinction - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therap … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Colossal Achieves Multiple Scientific Firsts in Progress Towards Thylacine De-Extinction October 17, 2024 | 11 min read Twitter LinkedIn Facebook Email Print Successes across the de-extinction pipeline signal that the thylacine project is on track as Colossal continues its global effort to fight the extin … icist and serial biotech entrepreneur George Church, Ph.D., and is the first to apply CRISPR technology for the purposes of species de-extinction. Colossal creates innovative technologies for species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. Colossal is accepting humanity's duty to restore Earth to a healthier state, while also solving for the future economies and biologica … intelligence Lilly, BMS, Incyte strike deals to keep biopharma’s AI integration rolling May 21, 2026 · 3 min read · Tristan Manalac Rare diseases BioMarin bounces back as Voxzogo performs ‘bigger than expected’ in new indication May 21, 2026 · 2 min read · Tristan Manalac Drug Development Beam one-ups Wave as both show promise of genetic editing for AATD May 20, 2026 · 2 min read · … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
"De-Extinction" Company Colossal Launches Form Bio to Maximize Tech - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Op … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search News Business “De-Extinction” Company Colossal Launches Form Bio to Maximize Tech September 27, 2022 | 2 min read | Paul Elias Twitter LinkedIn Facebook Email Print Photo courtesy of Form Bio Colossal started the “de-extinction” of the thylacine, commonly known as the Tasmania tiger. Now with … l biologist George Church launched the company on the back of CRISPR, the Nobel Prize-winning gene-editing technology. Lamm told BioSpace Colossal scientists and engineers have since created much of the necessary computational and work-a-day software from scratch. Lamm and Colossal representatives said their software can be used by other life sciences companies for similar uses. “When you have a big scientific endeavor like de-extincting a species, you not only need the smart … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Colossal Biosciences and the Vertebrate Genomes Project Sequence the Asian Elephant Genome, Chromosome to Chromosome - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Lone Star Bio Colossal Biosciences and the Vertebrate Genomes Project Sequence the Asian Elephant Genome, Chromosome to Chromosome July 12, 2022 | 5 min read Twitter LinkedIn Facebook Email Print Colossal Biosciences, a breakthrough biosciences and genetic engineering company, and the Vertebrate Genomes Project have bec … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Colossal Biosciences Expands De-extinction Portfolio with Iconic Bluebuck - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinio … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Colossal Biosciences Expands De-extinction Portfolio with Iconic Bluebuck April 30, 2026 | 20 min read Twitter LinkedIn Facebook Email Print The project, actively in progress, is powered by world-first breakthroughs in antelope reproduction and stem cell science; supported by local South African conservat … icist and serial biotech entrepreneur George Church, Ph.D., and is the first to apply CRISPR technology for the purposes of species de-extinction. Colossal creates innovative technologies for species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. Colossal is accepting humanity's duty to restore Earth to a healthier state, while also solving for the future economies and biologica … intelligence Lilly, BMS, Incyte strike deals to keep biopharma’s AI integration rolling May 21, 2026 · 3 min read · Tristan Manalac Rare diseases BioMarin bounces back as Voxzogo performs ‘bigger than expected’ in new indication May 21, 2026 · 2 min read · Tristan Manalac Drug Development Beam one-ups Wave as both show promise of genetic editing for AATD May 20, 2026 · 2 min read · … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Colossal Creates the Colossal Woolly Mouse, Showcasing Breakthroughs in Multiplex Genome Editing and Trait Engineering on the Path to a Mammoth - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manuf … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Colossal Creates the Colossal Woolly Mouse, Showcasing Breakthroughs in Multiplex Genome Editing and Trait Engineering on the Path to a Mammoth March 5, 2025 | 6 min read Twitter LinkedIn Facebook Email Print The Colossal Woolly Mouse expresses multiple mammoth-identified traits relevant to cold adaptatio … icist and serial biotech entrepreneur George Church, Ph.D., and is the first to apply CRISPR technology for the purposes of species de-extinction. Colossal creates innovative technologies for species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. Colossal is accepting humanity's duty to restore Earth to a healthier state, while also solving for the future economies and biologica … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Colossal buys animal cloning biotech in pursuit of de-extinction | STAT Skip to Main Content Manage alerts for this article Email this article Share this article Cancer ASCO research Newsletters Log In My Account Subscribe Now My Account Settings Complete your personal information for a more tailored experience Billing Log Out A decade of reporting from the frontiers of health and medicine Newsletters Log In My Account Subscribe Now Biotech Pharma Public Health Health Tech Policy Science First Opinion STAT+ STAT@ASCO Search Log In Try STAT+ My Account Home News Latest STAT10 Business Biotech P … C Davis School of Medicine. Letter to the editor Have an opinion on this essay? Submit a letter to the editor . ethics , genetics , STAT+ Submit a correction request Reprints Paul Knoepfler Newsletter The smartest thinkers in life sciences on what's happening — and what's to come Please enter a valid email address. Sign Up Your data will be processed in accordance with our Privacy Policy and Terms of Service . You may opt out of receiving STAT communications at any
How Colossal Biosciences is attempting to own the “woolly mammoth” | MIT Technology Review You need to enable JavaScript to view this site. Skip to Content MIT Technology Review Featured Topics Newsletters Events Audio MIT Technology Review Featured Topics Newsletters Events Audio Biotechnology and health Jurassic Patent: How Colossal Biosciences is attempting to own the “woolly mammoth” The company claiming it can restore lost species also wants to patent them. By Antonio Regalado archive page April 16, 2025 Colossal Biosciences Colossal Biosciences not only wants to bring back the woolly mam … pigs modified to grow organs for transplants. Colossal’s woolly mammoth patent application , with its descriptions of modified cells and animals, represents “the current standard in biotech cases,” says Cassie Edgar, a partner at the law firm McKee, Voorhees & Sease in Des Moines, Iowa. Yet Colossal’s legal venture breaks ground in other ways. It appears to be a novel attempt to secure rights to the use of extinct DNA and could establish an unprecedented legal monopoly o … s. “We need to ensure that we can protect our brand.” The existence of a patent application on mammoth-like elephants could tap into lingering public doubts over whether legal monopolies should really apply to living things, especially elephants, the world’s largest land animals. “There are people that are unhappy about that, but that is certainly a pattern we've seen for a while in the US,” says Alta Charo, a specialist in legal issues raised by biotechnology who is Colossal … now a biotech executive, was a student when he helped prepare an earlier patent application on engineered elephants, which the school filed in 2021. “I am not sure it should have an owner,” says Smith. “I have always been on the side that maybe the animals shouldn’t be patented.” During its press blitz last week, Colossal was careful not to reveal the exact genetic changes it had made to its wolves, telling advisors it needed to keep them secret for “intellectual-property rea … riants and animals whose bodies contain that genetic code. That is, this patent application doesn't cover any specific method or technology, but is instead aimed at securing rights to novel animals with genetic changes that alter their hair, body size, immune system, tolerance to cold, and even cognitive capacity. “Any animal with woolly mammoth
Colossal Closes $150M Series B with Eye on the Iconic Dodo - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releas … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Colossal Closes $150M Series B with Eye on the Iconic Dodo January 30, 2023 | 3 min read | Heather McKenzie Twitter LinkedIn Facebook Email Print Ben Lamm and Beth Shapiro, Ph.D., courtesy Colossa Tuesday, de-extinction company Colossal Biosciences closed a mammoth, $150 million Series B financing round and … the 17th century. The Series B, led by the United States Innovative Technology Fund (USIT) and supported by Breyer Capital, Bob Nelsen and Animal Capital, among others, brings Colossal’s total funding to date to $225 million. Colossal, founded in 2021 by famed geneticist George Church, debuted with the unusual mission to bring back the woolly mammoth . More specifically, the Dallas-based company aims to birth a cold-resistant elephant with all the core biological traits of t … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
George Church | Keynote Speaker | AAE Speakers Bureau 1.855.383.8805 Contact Us Speakers Topics Business Strategy Cybersecurity Diversity and Inclusion Education FinTech Future of Work History Leadership Mental Health Motivational Politics Social Activism Sports STEM Sustainability and Climate Change Work Life Balance >> View All Topics Resources About Contact Us 1.855.383.8805 Home Speakers George Church George Church Keynote Speaker: Geneticist, Molecular Engineer & Entrepreneur; Co-Founder, Colossal Biosciences; Professor & Leader of Synthetic Biology at the Wyss Institute Tra … ion. Church is also a recipient of numerous accolades, including the 2011 Bower Award and Prize for Achievement in Science from the Franklin Institute. He is an elected member of both the National Academy of Sciences and Engineering. In addition to his scientific exploits, Church authored "Regenesis: How Synthetic Biology Will Reinvent Nature and Ourselves," recognized as a "top science book" by New Scientist. Church also contributes regularly to Edge.org publications and vid … rtually any speaker or celebrity in the world. Our agents are happy and able to submit an offer to the speaker or celebrity of your choice, letting you benefit from our reputation and long-standing relationships in the industry. Please click the Check Schedule button above and complete the form on this page including the details of your event, or call our office at 1.855.383.8805 , and one of our agents will assist you to book George Church for your next private or corporate … rtually any speaker or celebrity in the world. Our agents are happy and able to submit an offer to the speaker or celebrity of your choice, letting you benefit from our reputation and long-standing relationships in the industry. Please click the Check Schedule button above and complete the form on this page including the details of your event, or call our office at 1.855.383.8805 , and one of our agents will assist you to book George Church for your next private or corporate … resident of The Game Changers Inc.; Former NFL Player View Profile Daymond John Award-Winning Entrepreneur; "Shark Tank" Investor; Founder & CEO of FUBU; Presidential Ambassador for Global Entrepreneurship View Profile Will Guidara Award-Winning Restaurateur, Entrepreneur & Bestselling Author of "Unreasonable Hospitality&qu
BioInformatics, Inc. - Drug pipelines, Patents, Clinical trials - Synapse Products Data Feature Plans Request Demo Sign Up for Free Last update 08 May 2025 BioInformatics, Inc. Subsidiary Company | 1994 | Virginia, United States | 50-100 | www.bioinfoinc.com Subsidiary Company | 1994 | Virginia, United States | 50-100 | www.bioinfoinc.com Last update 08 May 2025 Overview Pipeline Deal Translational Medicine Profit Grant & Funding(NIH) Investment Financing Overview Related 100 Clinical Results associated with BioInformatics, Inc. Login to view more data 0 Patents (Medical) associated with B … l biologist George Church launched the company on the back of CRISPR, the Nobel Prize-winning gene-editing technology. Lamm told BioSpace Colossal scientists and engineers have since created much of the necessary computational and work-a-day software from scratch. Lamm and Colossal representatives said their software can be used by other life sciences companies for similar uses. “When you have a big scientific endeavor like de-extincting a species, you not only need the smart … itions of over 360K organizations with Synapse. login or view full example data Grant & Funding(NIH) Access more than 2 million grant and funding information to elevate your research journey. login or view full example data Investment Gain insights on the latest company investments from start-ups to established corporations. login or view full example data Financing Unearth financing trends to validate and advance investment opportunities. login or view full example data